CancerPeptides.org

Why this name

Peptide oncology is not one approach but many: cell-penetrating carriers, neoantigen vaccines, radiolabeled targeting ligands, and conjugate payload delivery. The plural in CancerPeptides.org acknowledges that spread, and .org sets the tone as informational rather than transactional. It is the kind of address a reader trusts to survey a field honestly and cite its sources.

An advocacy organization, a disease-specific foundation funding peptide programs, or an editorial team producing clinical trial roundups all have a use for it. Because the name is generic in the useful sense, it can outlast any single research direction or funding cycle. A branded acronym would require years of explanation; this one is understood by anyone who reads the address bar.

Well suited to

• Disease foundation funding peptide research
• Clinical trial tracker for peptide oncology candidates
• Editorial review site covering peptide therapeutics
• Grant program or fellowship landing site

Ideal owner A cancer research foundation or advocacy organization with a peptide focus.